Aimmune Therapeutics

Nestlé to Sell Off Peanut Allergy Treatment, Not the Blockbuster They Hoped
Motley Fool
Tue, 11/29/22 - 11:00 pm
Nestle
peanut allergy
Aimmune Therapeutics
Palforzia
A Tale of 2 Biotechs With Competing Peanut Allergy Treatments
Motley Fool
Thu, 04/16/20 - 11:43 pm
peanut allergy
Viaskin Peanut
DBV Technologies
Aimmune Therapeutics
Palforzia
Palforzia Peanut Allergy Immunotherapy: Aimmune CEO on REMS, Manufacturing
Xconomy
Tue, 03/24/20 - 10:20 am
Aimmune Therapeutics
Palforzia
drug launches
REMS
Jayson Dallas
drug manufacturing
Why the FDA's Decision on Aimmune's Peanut Allergy Drug Is Crucial for the Company -- and Patients
Motley Fool
Fri, 01/10/20 - 10:42 am
Aimmune Therapeutics
FDA
Palforzia
peanut allergy
patients
Aimmune Presents New Peanut Allergy Data and Presses for Real-World Data Approaches
BioSpace
Sat, 11/9/19 - 12:07 pm
Aimmune Therapeutics
peanut allergy
AR101
real world data
RWE
Allergists Debate Anticipated FDA Approval Of A Peanut Allergy Drug
NPR
Mon, 09/23/19 - 07:30 pm
Aimmune Therapeutics
peanut allergy
Palforzia
An FDA advisory panel is reviewing Aimmune’s peanut allergy therapy. Here’s what’s happening
Stat
Fri, 09/13/19 - 10:18 am
FDA
advisory panels
peanut allergy
Aimmune Therapeutics
Palforzia
New peanut allergy therapies aren’t as effective — or nearly as inexpensive — as abstinence, says ICER
Endpoints
Thu, 07/11/19 - 12:03 pm
peanut allergy
Aimmune Therapeutics
DBV Technologies
ICER
AR101
Viaskin Peanut
Top 5 New Drug Launches of 2019 -- and the Biotech Stocks That Could Win Big
Motley Fool
Sun, 05/19/19 - 04:05 pm
Alexion
Ultomiris
AbbVie
Upadacitinib
risankizumab
Aimmune Therapeutics
AR-101
Bluebird Bio
LentiGlobin
FDA schedules Aimmune's peanut allergy drug for September expert review
Biopharma Dive
Thu, 05/16/19 - 12:01 pm
Aimmune Therapeutics
peanut allergy
FDA
AR101
4 Blockbuster Drug Launches to Watch in 2019
Motley Fool
Sun, 03/24/19 - 08:08 pm
drug launches
AbbVie
Alexion Pharmaceuticals
Aimmune Therapeutics
Skyrizi
psoriasis
Upadacitinib
rheumatoid arthritis
Ultomiris
PNH
AR101
peanut allergy
Aimmune has its answer on peanut drug's status, but how FDA proceeds still unclear
BioSpace
Fri, 03/1/19 - 08:30 pm
Aimmune Therapeutics
peanut allergy
FDA
AR101
[audio+transcript] 6 Biotech Stocks to Watch Now
Motley Fool
Fri, 02/1/19 - 10:36 pm
Biogen
Bluebird Bio
Global Blood Therapeutics
Aimmune Therapeutics
Vertex Pharmaceuticals
Sarepta Therapeutics
3 Potential New Drugs Held Up by the Shutdown
Motley Fool
Sat, 01/19/19 - 06:35 pm
FDA
government shutdown
Aimmune Therapeutics
AR 101
Celgene
fedratinib
Bristol-Myers Squibb
ozanimod
FDA’s Gottlieb Adds Confusion to Aimmune’s Claims of Shutdown Delay
Xconomy
Fri, 01/18/19 - 12:01 am
Aimmune Therapeutics
FDA
Scott Gottlieb
government shutdown
Aimmune says shutdown blocks peanut allergy drug review
Fierce Biotech
Tue, 01/15/19 - 09:53 am
Aimmune Therapeutics
peanut allergy
AR101
FDA
government shutdown
Aimmune's peanut allergy treatment could 'change practice' — with safety challenges and a price anything but peanuts
Endpoints
Mon, 11/19/18 - 09:51 am
Aimmune Therapeutics
AR101
peanut allergy
Nestlé ups its bet on Aimmune’s peanut allergy drug to $276M as NDA filing looms, rivalry intensifies
Endpoints
Mon, 11/12/18 - 11:41 pm
Nestle
Aimmune Therapeutics
peanut allergy